Kahun Medical
Evidence-based Clinical Reasoning Engine
Company Overview
Snapshot
Founded in October 2018 by Eitan Ron, Michal Tzuchman Katz, and Tal Goldberg, Kahun Medical operates with 11–50 employees. The company raised $13.5 million across 4 funding rounds from 4 investors. In April 2023, Kahun integrated AI chatbot ChatGPT into its system to enhance patient symptom description and diagnostic support.
Business overview
Kahun Medical develops an evidence-based clinical reasoning AI engine that leverages over 30 million mapped medical insights to perform gold-standard clinical assessments. This technology helps healthcare organizations optimize their clinical intake processes, improve physician efficiency, and achieve better clinical outcomes. Kahun's X-Gen-AI solution aims to close the clinical value gap by providing explainable AI clinical support and enabling transparent, explainable generative AI in healthcare. The company operates in the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, serving global markets including the United States.
Strategic signal
In April 2023, Kahun Medical integrated AI chatbot ChatGPT into its system, allowing patients to describe symptoms in natural language. This enhancement enables the AI to summarize conditions and suggest diagnoses to doctors, streamlining the clinical intake process. This development signals Kahun's commitment to leveraging advanced AI for improved patient engagement and diagnostic efficiency, positioning the company as an innovator in AI-driven medical decision support.
Log in to access full profile ›Company Intelligence Q&A
- What is Kahun Medical's primary offering?
- Kahun Medical offers an evidence-based clinical reasoning AI engine that utilizes over 30 million mapped medical insights to conduct gold-standard clinical assessments, optimizing clinical intake and supporting physicians.
- When was Kahun Medical founded and by whom?
- Kahun Medical was founded in October 2018 by Eitan Ron, Michal Tzuchman Katz, and Tal Goldberg.
- What was a significant product development for Kahun Medical in 2023?
- In April 2023, Kahun Medical integrated AI chatbot ChatGPT into its system to allow patients to describe symptoms in natural language, enhancing its diagnostic support capabilities.
- Which investors participated in Kahun Medical's Seed round in June 2022?
- In June 2022, Kahun Medical secured Seed funding from investors including LocalGlobe.
- What was Kahun Medical's response to the COVID-19 pandemic?
- In April 2020, Kahun Medical launched a free website and AI tool to help doctors and the public research the coronavirus, providing insights from millions of medical articles and supporting COVID-19 diagnosis.